THZ1 (5 and 10 mg/kg, twice per day) significantly hindered the growth of xenograft PDAC tumours in mice derived from CAPAN2 cells with KRAS‐G12V mutation in a dose‐dependent manner (Figure 2A,B). This evidence concerns the gene KRAS and neoplasm.